In addition, relapse-free survival rates of breast cancers (both HER2+ and HER2−) were negatively correlated with the level of Twist1, but positively correlated with BTG2 expression by open data analysis (Fig. 7b, c). This evidence concerns the gene ERBB2 and breast carcinoma.